Organization
Memo Therapeutics
3 clinical trials
Clinical trial
Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients, a Randomized Phase II/III Study, Double-blind and Placebo-controlledStatus: Recruiting, Estimated PCD: 2024-11-24
Clinical trial
A Phase l, Single-blind, Placebo-controlled Trial Designed to Assess the Safety and Tolerability of a Single Intravenous Dose of MTx-COVAB36 in Healthy Volunteers.Status: Completed, Estimated PCD: 2022-09-04
Clinical trial
A Phase 1, Single-blind, Partially Randomized, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Intravenous Doses of AntiBKV in Healthy Adult Volunteers.Status: Completed, Estimated PCD: 2022-12-05